Sarepta Therapeutics, Inc.
215 First Street
Cambridge, MA -2142
United States
884 articles about Sarepta Therapeutics, Inc.
-
AVI BioPharma, Inc. Announces Second Quarter 2008 Financial Results Conference Call
8/7/2008
-
AVI BioPharma, Inc. to Present at BMO Healthcare Conference
8/4/2008
-
AVI BioPharma, Inc. Appoints New Senior Vice President and Chief Financial Officer
7/28/2008
-
AVI BioPharma, Inc. Announces Partner's Advance in Cardiovascular Program
6/16/2008
-
AVI BioPharma, Inc. Publishes Preclinical Data in Muscular Dystrophy Research
6/12/2008
-
AVI BioPharma, Inc. Provides Update on New Business Plan: Discontinues Drug Program, Cuts Jobs
6/10/2008
-
AVI BioPharma, Inc. to Present at the 6th Annual Biodefense Vaccines and Therapeutics Meeting
6/9/2008
-
AVI BioPharma, Inc. to Present at the American Society of Gene Therapy Meeting
5/29/2008
-
AVI BioPharma, Inc. to Present at TIDES Meeting
5/20/2008
-
AVI BioPharma, Inc. Announces Significant Advance in the Potential Treatment of Ebola and Marburg Virus Infections
5/13/2008
-
AVI BioPharma, Inc. Announces First Quarter 2008 Financial Results Conference Call
5/8/2008
-
AVI BioPharma, Inc. Announces Dr. Ryszard Kole as Senior Vice President of Discovery Research
4/16/2008
-
AVI BioPharma, Inc. Announces Close of Ercole Biotech Acquisition
3/24/2008
-
AVI BioPharma, Inc. Announces Acquisition of Ercole Biotech
3/17/2008
-
AVI BioPharma, Inc. Announces Acquisition of Ercole Biotech
3/13/2008
-
AVI BioPharma, Inc. Announces 2007 Fourth Quarter and Full Year Financial Results
3/12/2008
-
AVI BioPharma, Inc. Names Dr. Leslie Hudson as Chief Executive Officer
2/11/2008
-
AVI BioPharma, Inc. Announces Commencement of Dosing in Clinical Trial for Duchenne Muscular Dystrophy
12/26/2007
-
AVI BioPharma, Inc. Completes Registered Direct Offering, Raises $20.3 Million
12/20/2007
-
AVI BioPharma, Inc. to Raise $20.3 Million in Registered Direct Offering
12/13/2007